Danaher Corp. (DHR) Shares Bought by Tocqueville Asset Management L.P.
Tocqueville Asset Management L.P. increased its position in shares of Danaher Corp. (NYSE:DHR) by 2.4% during the second quarter, Holdings Channel reports. The firm owned 55,736 shares of the company’s stock after buying an additional 1,317 shares during the period. Tocqueville Asset Management L.P.’s holdings in Danaher Corp. were worth $5,629,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors also recently bought and sold shares of the stock. Simmons Bank bought a new position in Danaher Corp. during the first quarter worth approximately $684,000. Arete Wealth Advisors LLC acquired a new position in shares of Danaher Corp. during the first quarter valued at about $336,000. Geode Capital Management LLC increased its position in shares of Danaher Corp. by 5.4% in the first quarter. Geode Capital Management LLC now owns 4,873,827 shares of the company’s stock valued at $461,393,000 after buying an additional 249,921 shares during the last quarter. Pictet Asset Management Ltd. increased its position in shares of Danaher Corp. by 0.4% in the first quarter. Pictet Asset Management Ltd. now owns 2,270,840 shares of the company’s stock valued at $202,718,000 after buying an additional 10,146 shares during the last quarter. Finally, Pacific Global Investment Management CO acquired a new position in shares of Danaher Corp. during the first quarter valued at about $206,000. 75.73% of the stock is currently owned by hedge funds and other institutional investors.
Shares of Danaher Corp. (NYSE:DHR) traded up 0.96% during trading on Wednesday, reaching $77.16. 2,765,248 shares of the company’s stock were exchanged. The company’s 50-day moving average price is $77.85 and its 200 day moving average price is $76.92. Danaher Corp. has a 52 week low of $61.60 and a 52 week high of $82.64. The firm has a market capitalization of $53.28 billion, a PE ratio of 15.35 and a beta of 1.13.
Danaher Corp. (NYSE:DHR) last released its quarterly earnings results on Monday, July 25th. The company reported $1.25 EPS for the quarter, topping the consensus estimate of $1.22 by $0.03. The business earned $5.80 billion during the quarter, compared to analyst estimates of $5.76 billion. Danaher Corp. had a net margin of 15.88% and a return on equity of 13.40%. The company’s quarterly revenue was up 16.6% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.08 earnings per share. Analysts predict that Danaher Corp. will post $3.56 EPS for the current fiscal year.
The company also recently declared a quarterly dividend, which will be paid on Friday, October 28th. Stockholders of record on Friday, September 30th will be given a dividend of $0.125 per share. The ex-dividend date of this dividend is Wednesday, September 28th. This represents a $0.50 annualized dividend and a dividend yield of 0.65%. Danaher Corp.’s dividend payout ratio is currently 9.94%.
DHR has been the topic of several research reports. Goldman Sachs Group Inc. initiated coverage on shares of Danaher Corp. in a research report on Tuesday, July 5th. They set a “neutral” rating and a $74.00 price objective on the stock. Zacks Investment Research raised shares of Danaher Corp. from a “hold” rating to a “buy” rating and set a $86.00 price objective on the stock in a research report on Tuesday, September 27th. Jefferies Group reissued a “buy” rating on shares of Danaher Corp. in a research report on Thursday, September 8th. Barclays PLC reissued an “overweight” rating and set a $105.00 price objective on shares of Danaher Corp. in a research report on Monday, June 27th. Finally, Sanford C. Bernstein raised shares of Danaher Corp. from a “market perform” rating to an “outperform” rating and set a $120.00 price objective on the stock in a research report on Thursday, June 23rd. Seven analysts have rated the stock with a hold rating and thirteen have given a buy rating to the stock. The company currently has an average rating of “Buy” and a consensus target price of $92.87.
In other news, CFO Daniel L. Comas sold 96,446 shares of the company’s stock in a transaction dated Wednesday, July 27th. The shares were sold at an average price of $80.88, for a total transaction of $7,800,552.48. Following the completion of the transaction, the chief financial officer now owns 215,716 shares in the company, valued at $17,447,110.08. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Thomas Patrick Joyce, Jr. sold 45,897 shares of the company’s stock in a transaction dated Monday, August 1st. The stock was sold at an average price of $81.44, for a total transaction of $3,737,851.68. Following the transaction, the insider now owns 179,054 shares of the company’s stock, valued at approximately $14,582,157.76. The disclosure for this sale can be found here. Insiders own 12.60% of the company’s stock.
Danaher Corp. Company Profile
Danaher Corporation designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates in five segments: Test & Measurement; Environmental; Life Sciences & Diagnostics; Dental, and Industrial Technologies. Its Test & Measurement segment offers products, software and services.
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corp. (NYSE:DHR).
Receive News & Ratings for Danaher Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corp. and related companies with MarketBeat.com's FREE daily email newsletter.